Blog Archives

ISPOR 19th ANNUAL EUROPEAN CONGRESS DREW KEY STAKEHOLDERS AND THOUGHT LEADERS TO DISCUSS ACCESS TO MEDICAL INNOVATIONS

ISPOR 19th Annual European Congress

Regulatory, Policy, and Financing Decisions in International Health Systems   Princeton, NJ—November 22, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recently concluded its 19th Annual European Congress in Vienna, Austria. More than 4,700 delegates—stakeholders from all sectors of

Tagged with: , , , , , , , ,
Posted in Announcements, ISPOR News & Press

PLENARY 2 OF ISPOR 19TH ANNUAL EUROPEAN CONGRESS FOCUSES ON DIFFERENTIAL PRICING OF MEDICINES IN EUROPE

Lou Garrison, PhD, Professor Emeritus, Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, WA, USA and ISPOR President (2016-2017)

Impact on Access, Innovation, and Affordability Vienna, Austria—1 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held its second plenary session, Differential Pricing of Medicines in Europe: Implications for Access, Innovation, and Affordability, this morning at the Society’s

Tagged with: , ,
Posted in Announcements, ISPOR News & Press

ISPOR 19TH ANNUAL EUROPEAN CONGRESS TO FOCUS ON MANAGING ACCESS TO MEDICAL INNOVATION

ISPOR Vienna 2016_Banner

Congress Scheduled for 29 October-2 November 2016 in Vienna Princeton, NJ—October 17, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced confirmation of the scientific sessions for its 19th Annual European Congress that will begin next week, 29 October-2

Tagged with: , , , , , , ,
Posted in Announcements, ISPOR News & Press
Categories
Follow ISPOR
RSS FeedFriend me on FacebookFollow my company on LinkedInFollow me on TwitterWatch me on YouTube